The U.S. Food and Drug Administration has approved an antibody, nirsevimab, which would protect newborns from R.S.V., respiratory syncytial virus....
respiratory syncytial virus.R.S.V.
The U.S. Food and Drug Administration has approved an antibody, nirsevimab, which would protect newborns from R.S.V., respiratory syncytial virus....
